2014 GLOBAL FORUM ON COMPETITION LOOKS AT PHARMACEUTICALS DISTRIBUTION MARKET
Pharmaceuticals are very special products, because of the peculiar characteristics of their demand and supply. Hence their distribution from the manufacturers till the final consumer is heavily regulated to ensure that drugs are accessible, affordable, and safely consumed. Despite this need for regulatory constraints, competition can and should play a role in ensuring that the market for the distribution of pharmaceuticals works well for consumers, so that these can benefit from higher quality, greater choice and variety, more innovation and lower prices.
The 2014 Global Forum on Competition (27-28 February) debated competition issues in the distribution of pharmaceuticals during its second day of discussions.
The full-day session provided an overview of how competition works in this market, to identify the main problems that can arise at different levels of the distribution chain and to better understand the interplay between competition and regulation.
Participants were encouraged to discuss competition cases, and the way regulations (or other forms of government intervention) interact with competition throughout the supply chain, and any advocacy efforts arising from such analysis.
Six experts lived up the discussion and delegations had the opportunity to further discuss the topic during breakout sessions in the afternoon.
See below the key findings from this discussion and all related documentation.
Generic Pharmaceuticals (2009)
Panellists, related papers and presentations
Contributions from participants